Psyence Biomedical Common Stock

As of the most recent data (September 2025), PBM shows a common stock of $69M. That compares with $53M in the prior-year period — up 30.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PBM's common stock is now $69M (was $53M) — a 30.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Psyence Biomedical is outperforming or lagging.

Tracking PBM's common stock over time shows whether Psyence Biomedical is scaling, shrinking, or reshaping that part of the business. The current reading is $69M That compares with $53M in the prior-year period — up 30.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Psyence Biomedical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $69M) with ownership activity and broader fundamentals.